Glutaraldehyde gelification time-a highly acceptable bedside tool in the assessment of children tuberculosis

Glutarldehyde gelification time (GGT) was determined three times in fifty-three children with the clinical diagnosis of tuberculosis supported by CxR evidence, once before the initiation of treatment (GGTO) and twice within six months of antituberculous treatment, at three months interval (GGT3 and GGT6 respectively). The values of GGTO are shortened in 46 cases (86.8 per cent). GGT3 and GGT6 revealed shorten in 27 cases (50.9 per cent) and 6 cases (11.3 per cent ) respectively. This significant change of GGT during treatment could be used as a supportive evidence to clinical judgment in the assessment of response to treatment in childhood tuberculosis.